Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01190358 · ClinicalTrials.gov registry record · NA
Grape Seed Extract and Postprandial Oxidation and Inflammation
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01190358 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 12 participants.
The verdict
NCT01190358, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether taking grape seed extract prior to eating a high fat meal will reduce the inflammatory response in people with the metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Grape seed extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2010-08 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01190358
The ClinicalTrials.gov registry entry for NCT01190358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01190358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01190358 about?
NCT01190358 is a clinical study titled "Grape Seed Extract and Postprandial Oxidation and Inflammation". The purpose of this study is to determine whether taking grape seed extract prior to eating a high fat meal will reduce the inflammatory response in people with the metabolic syndrome.
What is the current status of trial NCT01190358?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2010-08. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01190358?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Grape seed extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01190358?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.